Synopsis

Source of validity: Scientific
Rating (out of 5): 4

1,3, N-Dipropyl-7-Propargylxanthine (also known as DPPX) is a synthetic xanthine derivative primarily known as a potent and selective adenosine A_2A receptor antagonist. Adenosine receptors play a critical role in modulating neurotransmitter release in the central nervous system (CNS), particularly influencing dopamine, glutamate, and acetylcholine systems. By blocking A_2A receptors, DPPX can enhance dopaminergic and other neurotransmitter signaling. This mechanism has made adenosine receptor antagonists, including DPPX and related compounds, of interest in neuropharmacology—especially for conditions like Parkinson’s disease, where they can improve motor function and potentially cognitive symptoms by modulating neurotransmitter activity.

Multiple in vitro and in vivo studies have demonstrated that DPPX and similar compounds can increase neurotransmitter release and counteract adenosine-induced neuronal inhibition. In animal models, DPPX has been shown to potentiate dopamine release and improve behavioral outcomes related to neurotransmitter balance. While most clinical data are available for related compounds (such as istradefylline), the pharmacological rationale and preclinical evidence support DPPX’s role in influencing specific neurotransmitter systems. However, direct human clinical evidence for DPPX itself is limited; most support comes from mechanistic studies and animal data. Overall, use of DPPX to support the "Specific Neurotransmitters" body system is scientifically justified, with a moderate to strong evidence base primarily from preclinical research.

More about DMPX
More about Specific Neurotransmitters

Other ingredients that support Specific Neurotransmitters

Other body systems supported by DMPX

Products containing DMPX